LIGAND PHARMACEUTICALS INC
LGND
40 insider filings · Latest: Oct 2, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | Oct 6 8:35 PM | Andrew ReardonCLO & Secretary | Sale | 5,000 | $304.07 | $1.5M | 31,854(D) | View → |
| Sep 10, 2026 | Sep 14 8:59 PM | Martine ZimmermannDirector | Sale | 1,200 | $285.00 | $342.0K | 3,897(D) | View → |
| Sep 10, 2026 | Sep 10 8:01 PM | MARTINE ZIMMERMANN | Proposed Sale | 1,200 | $285.00 | $342.0K | — | View → |
| Sep 3, 2026 | Sep 8 10:34 PM | Andrew ReardonCLO & Secretary | Sale | 5,000 | $286.09 | $1.4M | 36,514(D) | View → |
| Sep 3, 2026 | Sep 3 8:40 PM | ANDREW REARDON | Proposed Sale | 15,000 | $286.92 | $4.3M | — | View → |
| Aug 12, 2026 | Aug 14 9:05 PM | Octavio EspinozaChief Financial Officer | Sale | 31,641 | $292.07 | $9.2M | 27,696(D) | View → |
| Aug 12, 2026 | Aug 14 9:04 PM | Jason HaasDirector | Sale | 7,138 | $292.81 | $2.1M | 3,981(D) | View → |
| Aug 12, 2026 | Aug 12 8:33 PM | OCTAVIO ESPINOZA | Proposed Sale | 31,641 | $288.75 | $9.1M | — | View → |
| Aug 12, 2026 | Aug 12 8:23 PM | Jason Haas | Proposed Sale | 7,138 | $292.81 | $2.1M | — | View → |
| Aug 3, 2026 | Aug 4 10:42 PM | Andrew ReardonCLO & Secretary | Sale | 5,000 | $288.99 | $1.4M | 41,514(D) | View → |
| Jul 1, 2026 | Jul 6 9:11 PM | Andrew ReardonCLO & Secretary | Sale | 5,000 | $313.28 | $1.6M | 41,514(D) | View → |
| Jul 1, 2026 | Jul 1 8:57 PM | ANDREW REARDON | Proposed Sale | 10,000 | $316.09 | $3.2M | — | View → |
| Jun 16, 2026 | Jun 18 12:37 PM | Stephen L SabbaDirector | Sale | 2,145 | $254.00 | $544.8K | 33,629(D) | View → |
| Jun 16, 2026 | Jun 16 8:30 PM | STEPHEN L. SABBA | Proposed Sale | 2,145 | $254.00 | $544.8K | — | View → |
| Jun 12, 2026 | Jun 16 1:06 AM | Jason HaasDirector | Sale | 6,461 | $255.58 | $1.7M | 4,981(D) | View → |
| Jun 11, 2026 | Jun 12 9:27 PM | Jason AryehDirector | Sale | 4,500 | $250.00 | $1.1M | 102,580(D) | View → |
| Jun 10, 2026 | Jun 12 9:27 PM | Jason AryehDirector | Sale | 500 | $250.00 | $125.0K | 107,080(D) | View → |
| Jun 10, 2026 | Jun 12 9:26 PM | John L LamattinaDirector | Sale | 4,591 | $250.88 | $1.2M | 26,969(D) | View → |
| Jun 12, 2026 | Jun 12 8:09 PM | JASON HAAS | Proposed Sale | 6,461 | $256.00 | $1.7M | — | View → |
| Jun 11, 2026 | Jun 11 4:21 PM | Aryeh Jason | Proposed Sale | 4,500 | $249.97 | $1.1M | — | View → |
Page 1 of 4
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | Mar 31 9:53 PM | John L LamattinaDirector | Option Exercise | 2,161 | $114.15 | 0(D) | View → |
| Mar 2, 2026 | Mar 28 1:20 AM | Octavio EspinozaChief Financial Officer | Grant/Award | 23,527 | $202.55 | 23,527(D) | View → |
| Mar 2, 2026 | Mar 28 12:33 AM | Todd C DavisDirector, Chief Executive Officer | Grant/Award | 50,058 | $202.55 | 50,058(D) | View → |
| Mar 2, 2026 | Mar 28 12:16 AM | Andrew ReardonCLO & Secretary | Grant/Award | 21,525 | $202.55 | 21,525(D) | View → |
| Mar 11, 2026 | Mar 13 11:29 PM | Octavio EspinozaChief Financial Officer | Option Exercise | 2,405 | $92.65 | 0(D) | View → |
| Mar 4, 2026 | Mar 6 11:51 PM | Andrew ReardonCLO & Secretary | Option Exercise | 5,000 | $52.27 | 54,444(D) | View → |
| Mar 4, 2026 | Mar 6 11:49 PM | Octavio EspinozaChief Financial Officer | Option Exercise | 2,073 | $80.72 | 0(D) | View → |
| Mar 3, 2026 | Mar 5 4:05 PM | Stephen L SabbaDirector | Option Exercise | 2,034 | $69.51 | 0(D) | View → |
← Previous
Page 2 of 2